持续性衣原体感染与关节炎

摘要/Abstract

摘要： 衣原体是专性细胞内寄生微生物,沙眼衣原体和肺炎衣原体对人类都有致病性。沙眼衣原体主要引起沙眼和非淋菌性尿道炎,肺炎衣原体是获得性肺炎的病原体之一。它们能够从最初感染部位向远处其他部位播散,并在该处长期存在下来。在感染和播散过程中,沙眼衣原体和肺炎衣原体均不产生毒素,但是会引起强烈的免疫病理反应,从而引发多种疾病,炎症性关节炎便是其中之一^[1]。一些衣原体感染引起的急性炎症性关节炎患者会演变成为慢性关节炎。

齐蔓莉, 田敬群, 傅志宜. 持续性衣原体感染与关节炎[J]. 中华皮肤科杂志, 2005, 38(5): 325-326.doi:

参考文献

[1] Inman RD, Whittum-Hudson JA, Schumacher HR, et al. Chlamydia and associated arthritis. Curr Opin Rheumatol, 2000,12: 254-262.
[2] Gerard HC, Branigan PJ, Schumacher HR Jr, et al. Synovial Chlamydia trachomatis in patients with reactive arthritis/Reiter's syndrome are viable but show aberrant gene expression. J Rheumatol, 1998, 25: 734-742.
[3] Beatty WL, Morrison RP, Byrne GI. Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. Microbiol Rev, 1994, 58: 686-699.
[4] Koehler L, Nettelnbreker E, Hudson AP, et al. Ultrastructural and molecular analyses of the persistence of Chlamydia trachomatis (serovar K) in human monocytes. Microb Pathog, 1997, 22: 133-142.
[5] Jones ML, Gaston JS, Pearce JH. Induction of abnormal Chlamydia trachomatis by exposure to interferon-gamma or amino acid deprivation and comparative antigenic analysis. Microb Pathog, 2001, 30: 299-309.
[6] Belland R J, Nelson DE, Virok D, et al. Transcriptome analysis of chlamydial growth during IFN-gamma-mediated persistence and reactivation. Proc Natl Acad Sci U S A,2003, 100: 15971-15976.
[7] Byrne GI, Ouellette SP, Wang Z, et al.Chlamydia pneumoniae expresses genes required for DNA replication but not cytokinesis during persistent infection of HEp-2cells. Infect Immun, 2001, 69: 5423-5429.
[8] 邵长庚,靳培英.Reiter综合征.中华皮肤科杂志,2003,36:56-58.
[9] Popov I, Dela Cruz CS, Barber BH, et al.Breakdown of CTL tolerance to self HLAB*2705 induced by exposure to Chlamydia trachomatis. J Immunol, 2002, 169: 4033-4038.
[10] Ramos M, Alvarez I, Sesma L, et al.Molecular mimicry of an HLA-B27-derived ligand of arthritis-linked subtypes with chlamydial proteins. J Biol Chem, 2002,277: 37573-37581.
[11] Hammerschlag MR, Golden NH, Oh MK, et al. Single dose of azithromycin for the treatment of genital chlamydial infections in adolescents. J Pediatr, 1993, 122: 961-965.
[12] Lauhio A, Leirisalo-Repo M, Lahdevirta J,et al. Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis. Arthritis Rheum, 1991, 34: 6-14.
[13] Bardin T, Enel C, Cornelis F, et al. Antibiotic treatment of venereal disease and Reiter's syndrome in a Greenland population.Arthritis Rheum, 1992, 35: 190-194.
[14] SieperJ, FendlerC, LaitkoS, et al. No benefit of long-term ciprofloxacin treatment in patients with reactive arthritis and undifferentiated oligoarthritis: a three-month,multicenter, double -blind, randomized,placebo-controlled study. Arthritis Rheum,1999, 42: 1386-1396.
[15] Laasila K, Laasonen L, Leirisalo-Repo M.Antibiotic treatment and long term prognosis of reactive arthritis. Ann Rheum Dis,2003, 62: 655-658.
[16] Gieffers J, Fullgraf H, Jahn J, et al.Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment. Circulation, 2001, 103:351-356.
[17] Ford DK, Schulzer M. Synovial lymphocytes indicate "bacterial" agents may cause some cases of rheumatoid arthritis. J Rheumatol,1994, 21: 1447-1449.
[18] Pando, JA, Yarboro, C, El Lallan, A, et al: Prevalence of Chlamydia trachomatis by PCR in the synovium of patients with early rheumatoid arthritis. Arthritis Rheum 1995,38: S287.
[19] Schumacher HR Jr, Gerard HC, Arayssi TK,et al.Lower prevalence of Chlamydia pneumoniae DNA compared with Chlamydia trachomatis DNA in synovial tissue of arthritis patients. Arthritis Rheum, 1999,42: 1889-1893.
[20] Hannu T, Puolakkainen M, Leirisalo-Repo M. Chlamydia pneumoniae as a triggering infection in reactive arthritis. Rheumatology,1999, 38:411-414.
[21] Gerard HC, Schumacher HR, El-Gabalawy H, et al. Chlamydia pneumoniae present in the human synovium are viable and metabolically active. Microb Pathog, 2000,29: 17-24.